MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Thursday reported a loss of $54 million in its fourth quarter.
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 44 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.
The molecular diagnostics company posted revenue of $143 million in the period, meeting Street forecasts.
For the year, the company reported that its loss widened to $175.1 million, or $1.43 per share. Revenue was reported as $454.5 million.
Exact Sciences expects full-year revenue in the range of $710 million to $730 million.
Exact Sciences shares have climbed 32 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $83.28, an increase of 79 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS